These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Sakai T; Kohno H; Ishihara T; Higaki M; Saito S; Matsushima M; Mizushima Y; Kitahara K Exp Eye Res; 2006 Apr; 82(4):657-63. PubMed ID: 16360654 [TBL] [Abstract][Full Text] [Related]
7. Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation. Xiong T; Li X; Zhou Y; Song Q; Zhang R; Lei L; Li X Acta Biomater; 2018 Jun; 73():275-284. PubMed ID: 29660509 [TBL] [Abstract][Full Text] [Related]
8. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis. Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407 [TBL] [Abstract][Full Text] [Related]
9. A combination of inhibiting microglia activity and remodeling gut microenvironment suppresses the development and progression of experimental autoimmune uveitis. Zhou J; Yang J; Dai M; Lin D; Zhang R; Liu H; Yu A; Vakal S; Wang Y; Li X Biochem Pharmacol; 2020 Oct; 180():114108. PubMed ID: 32569628 [TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of infliximab encapsulated in liposomes. Zhang R; Qian J; Li X; Yuan Y Br J Ophthalmol; 2017 Dec; 101(12):1731-1738. PubMed ID: 28986343 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis. Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913 [TBL] [Abstract][Full Text] [Related]
13. Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis. Whitcup SM; Robinson MR Ann N Y Acad Sci; 2015 Nov; 1358():1-12. PubMed ID: 26200808 [TBL] [Abstract][Full Text] [Related]
14. Effects of a new dexamethasone-delivery system (Surodex) on experimental intraocular inflammation models. Kodama M; Numaga J; Yoshida A; Kaburaki T; Oshika T; Fujino Y; Wu GS; Rao NA; Kawashima H Graefes Arch Clin Exp Ophthalmol; 2003 Nov; 241(11):927-33. PubMed ID: 14652765 [TBL] [Abstract][Full Text] [Related]
15. Calcium ion coordinated dexamethasone supramolecular hydrogel as therapeutic alternative for control of non-infectious uveitis. Wu W; Zhang Z; Xiong T; Zhao W; Jiang R; Chen H; Li X Acta Biomater; 2017 Oct; 61():157-168. PubMed ID: 28501709 [TBL] [Abstract][Full Text] [Related]
17. Subconjunctival injection of rapamycin-loaded polymeric microparticles for effective suppression of noninfectious uveitis in rats. Mo L; Deng M; Chen J; Huai S; Du L; Xu X; Guo Q; Chen H; Li X; Bao Z Int J Pharm; 2024 May; 657():124178. PubMed ID: 38692499 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal injection of rapamycin-loaded polymeric micelles for inhibition of ocular inflammation in rat model. Wu W; He Z; Zhang Z; Yu X; Song Z; Li X Int J Pharm; 2016 Nov; 513(1-2):238-246. PubMed ID: 27609662 [TBL] [Abstract][Full Text] [Related]
19. Sustained release ophthalmic dexamethasone: In vitro in vivo correlations derived from the PK-Eye. Awwad S; Day RM; Khaw PT; Brocchini S; Fadda HM Int J Pharm; 2017 Apr; 522(1-2):119-127. PubMed ID: 28232270 [TBL] [Abstract][Full Text] [Related]
20. A Low Concentration of Tacrolimus/Semifluorinated Alkane (SFA) Eyedrop Suppresses Intraocular Inflammation in Experimental Models of Uveitis. De Majumdar S; Subinya M; Korward J; Pettigrew A; Scherer D; Xu H Curr Mol Med; 2017; 17(3):211-220. PubMed ID: 28782485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]